Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone-iodine + isopropyl alcohol + methylprednisolone acetate + lidocaine
- Development stage
- Unknown
- Lead developer
- Asclemed USA
- Modality
- Small Molecules
- Administration
- Intramuscular, Intraarticular, Intralesional, Parenteral, Topical
01
Overview
**povidone-iodine + isopropyl alcohol + methylprednisolone acetate + lidocaine** is a combination kit product marketed as **Dyural L Kit** by **Asclemed USA**. It combines **methylprednisolone acetate**, a depot synthetic glucocorticoid corticosteroid, with **lidocaine**, a local anesthetic, plus **povidone-iodine** and **isopropyl alcohol** as antiseptic skin-preparation components supplied in the kit. The pharmacologically primary therapeutic component is methylprednisolone acetate, which acts through the **glucocorticoid receptor** to suppress inflammatory and immune responses; lidocaine provides local sodium-channel blockade for procedural analgesia. The product is used in injectable corticosteroid administration settings including intramuscular, intra-articular, soft tissue, and intralesional use for a broad range of inflammatory, rheumatologic, dermatologic, allergic, hematologic, and related conditions. Based on the provided context, this product is marketed but its labeling has **not been approved by the FDA as safe and effective**.
- Brand names
- Dyural L Kit
- Other names
- povidone-iodine + isopropyl alcohol + methylprednisolone acetate + lidocainemethylprednisolone acetate + lidocaine + povidone-iodine + isopropyl alcohol
02
Targets
GR (Glucocorticoid receptor)SCN5A (Sodium channel protein type 5 subunit alpha)MR (Mineralocorticoid receptor)Microbial biomolecules (proteins, lipids, and nucleic acids)
Beyond the preview
Go deeper on povidone-iodine + isopropyl alcohol + methylprednisolone acetate + lidocaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on povidone-iodine + isopropyl alcohol + methylprednisolone acetate + lidocaine.